Coordination & Organisation
OLiMPE
88 rue du Dôme, 92100 Boulogne-Billancourt / Téléphone : +33 (0)1 83 64 43 44 / Mail contact : contact@phases-precoces.fr
Appartient au groupe
Pr Christophe LE TOURNEAU, MD, PhD
Expert en Oncologie ORL et Essais Cliniques Précoces au sein du Département d’Oncologie Médicale de l’institut Godinot – Reims
Christophe Le Tourneau is a senior Medical Oncologist curently working at Godinot Institute in Reims. He has worked at the Institut Curie and Gustave Roussy, and is Professor of Medicine at Paris-Saclay University. His main areas of expertise are Head and Neck Oncology and early Drug Development.
Christophe Le Tourneau was certified in Medical Oncology in 2005 and got his PhD in Clinical Epidemiology in 2007. He did a 2-year Clinical Research Fellowship at Princess Margaret Hospital in Toronto, Canada, in the Drug Development Program.
His main interests are precision medicine, phase I clinical trials with a special attention at the methodology to conduct these trials, as well as Head and Neck oncology. Christophe Le Tourneau is the principal investigator of numerous phase I and II trials, as well as of clinical trials in Head and Neck oncology. He ran the first randomized precision medicine trial (SHIVA01) that compared the efficacy of matched targeted therapy versus conventional chemotherapy in patients with advanced cancer. Christophe Le Tourneau is leading several precision medicine projects at the national and international level.
Christophe has participated in the Developmental Therapeutics track of the ASCO from 2017 to 2019 and has been the track leader in 2018. He is very much incolved at the ESMO, leading the Drug Development track for ESMO 2027 and being president of the 2028 ICHNO meeting. He has published 340+ peer-reviewed papers in international journals.